Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001140361-26-026568
Filing Date
2026-06-26
Accepted
2026-06-26 16:19:40
Documents
21

Document Format Files

Seq Description Document Type Size
1 S-3 ny20076831x1_s3.htm S-3 299238
2 EXHIBIT 4.2 ny20076831x1_ex4-2.htm EX-4.2 90380
3 EXHIBIT 5.1 ny20076831x1_ex5-1.htm EX-5.1 15350
4 EXHIBIT 10.1 ny20076831x1_ex10-1.htm EX-10.1 141772
5 EXHIBIT 10.2 ny20076831x1_ex10-2.htm EX-10.2 978559
6 EXHIBIT 10.3 ny20076831x1_ex10-3.htm EX-10.3 356688
7 EXHIBIT 23.1 ny20076831x1_ex23-1.htm EX-23.1 2725
8 FILING FEES TABLE ny20076831_ex107.htm   iXBRL EX-FILING FEES 30933
9 logo_aquestive.jpg GRAPHIC 26566
10 logo_aquestivex1.jpg GRAPHIC 43976
11 ny20076831x1_ex5-1img01.jpg GRAPHIC 19990
12 ny20076831x1_ex23-1img02.jpg GRAPHIC 2436
  Complete submission text file 0001140361-26-026568.txt   2170632

Data Files

Seq Description Document Type Size
24 EXTRACTED XBRL INSTANCE DOCUMENT ny20076831_ex107_htm.xml XML 6769
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-297069 | Film No.: 261129648
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)